170 related articles for article (PubMed ID: 36273492)
1. Resistance to ATR Inhibitors Is Mediated by Loss of the Nonsense-Mediated Decay Factor UPF2.
O'Leary PC; Chen H; Doruk YU; Williamson T; Polacco B; McNeal AS; Shenoy T; Kale N; Carnevale J; Stevenson E; Quigley DA; Chou J; Feng FY; Swaney DL; Krogan NJ; Kim M; Diolaiti ME; Ashworth A
Cancer Res; 2022 Nov; 82(21):3950-3961. PubMed ID: 36273492
[TBL] [Abstract][Full Text] [Related]
2. SMG8/SMG9 Heterodimer Loss Modulates SMG1 Kinase to Drive ATR Inhibitor Resistance.
Llorca-Cardenosa MJ; Aronson LI; Krastev DB; Nieminuszczy J; Alexander J; Song F; Dylewska M; Broderick R; Brough R; Zimmermann A; Zenke FT; Gurel B; Riisnaes R; Ferreira A; Roumeliotis T; Choudhary J; Pettitt SJ; de Bono J; Cervantes A; Haider S; Niedzwiedz W; Lord CJ; Chong IY
Cancer Res; 2022 Nov; 82(21):3962-3973. PubMed ID: 36273494
[TBL] [Abstract][Full Text] [Related]
3. Loss of Cyclin C or CDK8 provides ATR inhibitor resistance by suppressing transcription-associated replication stress.
Lloyd RL; Urban V; Muñoz-Martínez F; Ayestaran I; Thomas JC; de Renty C; O'Connor MJ; Forment JV; Galanty Y; Jackson SP
Nucleic Acids Res; 2021 Sep; 49(15):8665-8683. PubMed ID: 34329458
[TBL] [Abstract][Full Text] [Related]
4. Metronomic dosing of ovarian cancer cells with the ATR inhibitor AZD6738 leads to loss of CDC25A expression and resistance to ATRi treatment.
Ao W; Kim HI; Tommarello D; Conrads KA; Hood BL; Litzi T; Abulez T; Teng PN; Dalgard CL; Zhang X; Wilkerson MD; Darcy KM; Tarney CM; Phippen NT; Bakkenist CJ; Maxwell GL; Conrads TP; Risinger JI; Bateman NW
Gynecol Oncol; 2023 Oct; 177():60-71. PubMed ID: 37639904
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of [
Carlucci G; Carney B; Sadique A; Vansteene A; Tang J; Reiner T
Nucl Med Biol; 2017 May; 48():9-15. PubMed ID: 28157626
[TBL] [Abstract][Full Text] [Related]
6. Structural and functional analysis of the three MIF4G domains of nonsense-mediated decay factor UPF2.
Clerici M; Deniaud A; Boehm V; Gehring NH; Schaffitzel C; Cusack S
Nucleic Acids Res; 2014 Feb; 42(4):2673-86. PubMed ID: 24271394
[TBL] [Abstract][Full Text] [Related]
7. An alternative spliced UPF2 transcript in pancreatic inflammatory myofibroblastic tumors.
Jiang H; Zhang Y; Hu J; Wang Z; Li G; Lu Y
Biochem Biophys Res Commun; 2024 Jan; 691():149306. PubMed ID: 38056247
[TBL] [Abstract][Full Text] [Related]
8. Targeting the DNA Damage Response Pathways and Replication Stress in Colorectal Cancer.
Durinikova E; Reilly NM; Buzo K; Mariella E; Chilà R; Lorenzato A; Dias JML; Grasso G; Pisati F; Lamba S; Corti G; Degasperi A; Cancelliere C; Mauri G; Andrei P; Linnebacher M; Marsoni S; Siena S; Sartore-Bianchi A; Nik-Zainal S; Di Nicolantonio F; Bardelli A; Arena S
Clin Cancer Res; 2022 Sep; 28(17):3874-3889. PubMed ID: 35881546
[TBL] [Abstract][Full Text] [Related]
9. Human nonsense-mediated mRNA decay factor UPF2 interacts directly with eRF3 and the SURF complex.
López-Perrote A; Castaño R; Melero R; Zamarro T; Kurosawa H; Ohnishi T; Uchiyama A; Aoyagi K; Buchwald G; Kataoka N; Yamashita A; Llorca O
Nucleic Acids Res; 2016 Feb; 44(4):1909-23. PubMed ID: 26740584
[TBL] [Abstract][Full Text] [Related]
10. A Synthetic Lethal Screen Identifies DNA Repair Pathways that Sensitize Cancer Cells to Combined ATR Inhibition and Cisplatin Treatments.
Mohni KN; Thompson PS; Luzwick JW; Glick GG; Pendleton CS; Lehmann BD; Pietenpol JA; Cortez D
PLoS One; 2015; 10(5):e0125482. PubMed ID: 25965342
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of Upf2-Dependent Nonsense-Mediated Decay Leads to Behavioral and Neurophysiological Abnormalities by Activating the Immune Response.
Johnson JL; Stoica L; Liu Y; Zhu PJ; Bhattacharya A; Buffington SA; Huq R; Eissa NT; Larsson O; Porse BT; Domingo D; Nawaz U; Carroll R; Jolly L; Scerri TS; Kim HG; Brignell A; Coleman MJ; Braden R; Kini U; Jackson V; Baxter A; Bahlo M; Scheffer IE; Amor DJ; Hildebrand MS; Bonnen PE; Beeton C; Gecz J; Morgan AT; Costa-Mattioli M
Neuron; 2019 Nov; 104(4):665-679.e8. PubMed ID: 31585809
[TBL] [Abstract][Full Text] [Related]
12. Nonsense in the testis: multiple roles for nonsense-mediated decay revealed in male reproduction.
MacDonald CC; Grozdanov PN
Biol Reprod; 2017 May; 96(5):939-947. PubMed ID: 28444146
[TBL] [Abstract][Full Text] [Related]
13. Functionally-instructed modifiers of response to ATR inhibition in experimental glioma.
Walter B; Hirsch S; Kuhlburger L; Stahl A; Schnabel L; Wisser S; Haeusser LA; Tsiami F; Plöger S; Aghaallaei N; Dick AM; Skokowa J; Schmees C; Templin M; Schenke-Layland K; Tatagiba M; Nahnsen S; Merk DJ; Tabatabai G
J Exp Clin Cancer Res; 2024 Mar; 43(1):77. PubMed ID: 38475864
[TBL] [Abstract][Full Text] [Related]
14. Rotaviral nonstructural protein 5 (NSP5) promotes proteasomal degradation of up-frameshift protein 1 (UPF1), a principal mediator of nonsense-mediated mRNA decay (NMD) pathway, to facilitate infection.
Sarkar R; Banerjee S; Mukherjee A; Chawla-Sarkar M
Cell Signal; 2022 Jan; 89():110180. PubMed ID: 34718106
[TBL] [Abstract][Full Text] [Related]
15. The Role of ATR Inhibitors in Ovarian Cancer: Investigating Predictive Biomarkers of Response.
Bradbury A; Zenke FT; Curtin NJ; Drew Y
Cells; 2022 Aug; 11(15):. PubMed ID: 35954206
[TBL] [Abstract][Full Text] [Related]
16. Comparison of EJC-enhanced and EJC-independent NMD in human cells reveals two partially redundant degradation pathways.
Metze S; Herzog VA; Ruepp MD; Mühlemann O
RNA; 2013 Oct; 19(10):1432-48. PubMed ID: 23962664
[TBL] [Abstract][Full Text] [Related]
17. Contribution of copy number variants involving nonsense-mediated mRNA decay pathway genes to neuro-developmental disorders.
Nguyen LS; Kim HG; Rosenfeld JA; Shen Y; Gusella JF; Lacassie Y; Layman LC; Shaffer LG; Gécz J
Hum Mol Genet; 2013 May; 22(9):1816-25. PubMed ID: 23376982
[TBL] [Abstract][Full Text] [Related]
18. Distinct but Concerted Roles of ATR, DNA-PK, and Chk1 in Countering Replication Stress during S Phase.
Buisson R; Boisvert JL; Benes CH; Zou L
Mol Cell; 2015 Sep; 59(6):1011-24. PubMed ID: 26365377
[TBL] [Abstract][Full Text] [Related]
19. A highly conserved region essential for NMD in the Upf2 N-terminal domain.
Fourati Z; Roy B; Millan C; Coureux PD; Kervestin S; van Tilbeurgh H; He F; Usón I; Jacobson A; Graille M
J Mol Biol; 2014 Nov; 426(22):3689-3702. PubMed ID: 25277656
[TBL] [Abstract][Full Text] [Related]
20. Human UPF3A and UPF3B enable fault-tolerant activation of nonsense-mediated mRNA decay.
Wallmeroth D; Lackmann JW; Kueckelmann S; Altmüller J; Dieterich C; Boehm V; Gehring NH
EMBO J; 2022 May; 41(10):e109191. PubMed ID: 35451084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
